FMW
IDXX icon

Farr Miller & Washington’s Idexx Laboratories IDXX Stock Holding History

Farr Miller & Washington’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$266K Hold
428
– – 0.02% 164
2021
Q2 		$270K Hold
428
– – 0.02% 165
2021
Q1 		$209K Buy
428
+2
+0.5% +$1K 0.01% 180
2020
Q4 		$213K Buy
+426
New +$191K 0.02% 171

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Farr Miller & Washington's IDXX Position: Q3 2021 in Review

Farr Miller & Washington held its Idexx Laboratories (IDXX) position steady in Q3 2021 at 428 shares worth $266K. The position accounts for 0.02% of the portfolio, ranked #164.

Farr Miller & Washington first reported a position in IDXX in Q4 2020 and has held it in 4 quarters since. The position peaked at $270K in Q2 2021. 1,058 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.

  • Farr Miller & Washington held 428 shares of Idexx Laboratories worth $266K as of Q3 2021.
  • Farr Miller & Washington left its Idexx Laboratories share count unchanged in Q3 2021.
  • Idexx Laboratories made up 0.02% of Farr Miller & Washington's portfolio in Q3 2021, its #164 holding.
  • Farr Miller & Washington first reported a position in Idexx Laboratories in Q4 2020 and has held it in 4 quarters since.
  • Farr Miller & Washington's Idexx Laboratories position peaked at $270K in Q2 2021.
  • 1,058 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.

Based on Farr Miller & Washington's 13F filing for Q3 2021, filed 15 Nov 2021.